Cambridge Investment Research Advisors, Inc. Moderna, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 20,876 shares of MRNA stock, worth $769,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,876

Previous 24,450 14.62%

Holding current value

$769,280

Previous $2.9 Million 51.95%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$63.64 - $125.14 $227,449 - $447,250	-3,574 Reduced 14.62%	20,876 $1.4 Million
Q2 2024 Jul 26, 2024	SELL	$101.21 - $166.61 $135,216 - $222,590	-1,336 Reduced 5.18%	24,450 $2.9 Million
Q1 2024 Apr 24, 2024	BUY	$85.37 - $115.44 $222,388 - $300,721	2,605 Added 11.24%	25,786 $2.75 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $439,928 - $660,937	-6,329 Reduced 21.45%	23,181 $2.31 Million
Q3 2023 Oct 24, 2023	SELL	$96.41 - $126.61 $1.01 Million - $1.32 Million	-10,434 Reduced 26.12%	29,510 $3.05 Million
Q2 2023 Jul 13, 2023	SELL	$118.5 - $160.53 $1.89 Million - $2.56 Million	-15,927 Reduced 28.51%	39,944 $4.85 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $1.98 Million - $2.87 Million	14,560 Added 35.24%	55,871 $8.58 Million
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $331,108 - $587,481	2,797 Added 7.26%	41,311 $7.42 Million
Q3 2022 Oct 17, 2022	SELL	$118.07 - $194.18 $210,046 - $345,446	-1,779 Reduced 4.42%	38,514 $4.55 Million
Q2 2022 Jul 13, 2022	BUY	$117.13 - $176.59 $715,430 - $1.08 Million	6,108 Added 17.87%	40,293 $5.76 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $513,933 - $955,243	-4,064 Reduced 10.63%	34,185 $5.89 Million
Q4 2021 Feb 03, 2022	SELL	$225.82 - $368.51 $4.53 Million - $7.39 Million	-20,059 Reduced 34.4%	38,249 $9.71 Million
Q3 2021 Nov 02, 2021	BUY	$221.9 - $484.47 $4.06 Million - $8.86 Million	18,296 Added 45.73%	58,308 $22.4 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $1.52 Million - $2.75 Million	-11,721 Reduced 22.66%	40,012 $9.4 Million
Q1 2021 May 07, 2021	BUY	$109.18 - $185.98 $50,004 - $85,178	458 Added 0.89%	51,733 $6.77 Million
Q4 2020 Feb 04, 2021	SELL	$65.74 - $169.86 $1.23 Million - $3.18 Million	-18,720 Reduced 26.74%	51,275 $5.36 Million
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $339,896 - $593,286	6,255 Added 9.81%	69,995 $4.95 Million
Q2 2020 Jul 27, 2020	SELL	$29.67 - $80.0 $5.09 Million - $13.7 Million	-171,556 Reduced 72.91%	63,740 $4.09 Million
Q1 2020 May 08, 2020	SELL	$17.78 - $31.58 $1.94 Million - $3.45 Million	-109,295 Reduced 31.72%	235,296 $7.05 Million
Q4 2019 Feb 04, 2020	SELL	$13.93 - $21.28 $693,853 - $1.06 Million	-49,810 Reduced 12.63%	344,591 $6.74 Million
Q3 2019 Nov 06, 2019	BUY	$12.26 - $18.07 $4.84 Million - $7.13 Million	394,401 New	394,401 $6.28 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Moderna, Inc. Transaction History